Neuroelectrics is a Spanish company pioneer in brain stimulation and artificial intelligence technologies and therapies to alleviate neurological diseases.

Founded in 2011 and headquartered in Barcelona and Boston, Neuroelectrics distributes its products in more than 40 countries for basic neuroscience and clinical research in hundreds of universities and academic medical centers. Their vision is to create a powerful neurotechnology platform upon which verticals can be developed to improve the lives of as many people as possible. Clinical applications are already being developed to diagnose and treat brain diseases as well as improve brain health (e.g., in epilepsy, neuropathic pain, or mood disorders) and cognitive function (e.g., memory in dementia or executive function in children with ADHD).